Join us at AACR
April 25 – 30, 2025 • Chicago, IL • Booth #1032
ChemPartner is a global CRO offering integrated discovery and development services with deep expertise in oncology and immuno-oncology. From early-stage target discovery through IND-enabling studies, our scientific teams specialize in antibody-drug conjugates, small molecules, oligonucleotides, and emerging therapeutic modalities.
We’re excited to share our latest innovations at AACR 2025. If you’re exploring new strategies in cancer research, connect with us to see how our platforms, data-driven approach, and collaborative mindset can support your pipeline.
Let’s start the conversation.
Featured Posters at AACR 2025
Explore our latest oncology research and platform innovations at AACR 2025. Our scientists will present five posters highlighting our integrated capabilities across antibody-drug conjugates, targeted therapies, oligonucleotides, and advanced 3D cell models.
- Development and Preclinical Characterization of HER2×Trop-2 Bispecific Antibody-Drug Conjugates (bsADCs) With Auristatin Microtubule Inhibitors
- An Integrated End-to-End Platform Facilitating the Evaluation of Next Generation KRAS Inhibitors
- An Integrated Oligonucleotide Synthesis and Cellular In Vitro Assay Platform to Support Oligonucleotide-Based Drug Discovery and Development
- A Comparison of Spheroid Formation Using AcroCyte‘s 3-Dimensional R3CE Spheroid Culture Platform Versus Traditional 3D Culture Methods
- A Customizable, End-to-End Platform for the Screening and Characterization of ADCs
Let's Connect
Headquarters
1F & 3F, Block A
2829 JinKe Road
Zhangjiang Hi-Tech Park
PuDong New Area
Shanghai China, 201203
Contact Us
China: +86 21 5132 0088
US: +1 650 419 9974
Europe: +45 4586 9000